anti clotting drugs Flashcards
classes of drugs for anti clotting
- antiplatelet
- anticoagulants
- thrombolytics
name the 4 antiplatelet drugs
- aspirin
- GP2b/3a receptor blockers
- ADP receptor blockers
- PDE inhibitors
which prostanoids are heavily involved in primary hemostasis
PGI2 (anti thrombotic)
TXA2 (pro thrombotic)
what does PGI2 do in primary hemostasis
- helathy intact endothelium release PGI2 into plasma
- PGI2 blinds to platelet membrane receptors –> conversion of ATP to cAMP
- cAMP inhibits release of granules containing aggregating agents (serotonin, ADP)
what does TXA2 do in primary hemostasis
- thrombin + TXA2 + subendothelial collagen cause release of arachidonic acid from platelet membrane
- TXA2 is synthesised from archidonic acid in platelet, then released
- TXA2 binds to receptors on other platelets, inititaes release of additional aggregating agents (serotonin, ADP)
aspirin MOA
- irreversible nonselective COX inhibitor –> no production of prostanoids from arachidonic acid
- antiplatelet effect as PGI2 can be restored, TXA2 cannot
=> overall antiplatelet effect
aspirin PK
rapid inhibitory effect that lasts for the platelet lifespan (7-10 days) as it is irreversible inhibitor
aspirin clinical uses
- prophylactic treatment of transient cerebral ischemia (BUT recent studies indicate against use if there is no history of cerebral infarct, MI, etc.)
- reduce incidence of recurrent MI
- decrease mortality in post MI patients
aspirin adverse effects
- gastic upset and ulcers
what do gp2b/3a receptors do in primary hemostasis
for platelet aggregation
- for fibrinogen and vitrionectin binding - cross link platelets
- for fibronectin and vWF binding
- activation of this receptor is final common pathway for platelet aggregation
name 3 gp2b/3a receptors blockers
abciximab, eptifibatide, tirofiban
gp 2b/3a receptor blockers MOA
displace fibrinogen that is cross linking platelets on existing thrombi –> prevent further platelet cross linking and thrombosis
=> prevents clot formation
how does abciximab displace fibrinogen
humanised Ab that reversibly inhibits binding of fibrinogen and other ligands
how does eptifibatide displace fibrinogen
analog of sequence at C terminal of delta chain of fibrinogen, which mediates binding of fibrinogen to receptor
thus preventing binding between fibrinogen and receptor
how does tirofiban displace fibrinogen
tirofiban is a small molecule receptor blocker
gp 2b/3a receptor blocker clinical uses
- prevent restenosis after coronary angioplasty
2. acute coronary syndromes (to prevent possible thrombus formation)
name 2 ADP receptor blockers
clopidogrel, ticlopidine
ADP receptor blocker MOA
prevent binding of ADP to ADP receptors –> reduce platelet aggregation